Related Experiment Videos
[ST segment elevation, right bundle branch block and sudden death: Brugada's syndrome]
Archivos Del Instituto De Cardiologia De Mexico
|August 26, 2000
Summary
Brugada syndrome, an electrical heart condition caused by SCN5A gene mutations, leads to sudden death. The implantable cardioverter defibrillator (ICD) is the only effective treatment, drastically reducing mortality.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Context:
- Brugada syndrome is a primary cause of sudden cardiac death in young adults.
- It is an inherited electrical disorder linked to SCN5A gene mutations.
- The condition affects cardiac sodium channels, leading to arrhythmias.
Purpose:
- To explain the genetic basis and pathophysiology of Brugada syndrome.
- To outline the clinical presentation and diagnostic methods.
- To highlight the efficacy of the implantable cardioverter defibrillator (ICD) in managing the condition.
Summary:
- Brugada syndrome results from SCN5A gene mutations affecting cardiac sodium channels, causing abnormal action potentials.
- Characteristic ECG findings include right bundle branch block and ST elevation (V1-V3).
- Pharmacological tests with ajmaline or procainamide can unmask ECG changes in ambiguous cases.
Impact:
- The implantable cardioverter defibrillator (ICD) significantly reduces annual mortality from 40% to 0% over ten years.
- Current pharmacological treatments are ineffective for Brugada syndrome.
- Understanding the genetic and electrical basis is crucial for effective management and prevention of sudden cardiac death.